CINECA IRIS Institutional Research Information System

BALDOVINO, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.905
EU - Europa 5.338
AS - Asia 3.260
SA - Sud America 733
AF - Africa 122
OC - Oceania 93
Continente sconosciuto - Info sul continente non disponibili 22
Totale 17.473
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.425
IT - Italia 1.737
CN - Cina 1.333
FR - Francia 469
DE - Germania 444
IE - Irlanda 405
JP - Giappone 386
ES - Italia 367
SG - Singapore 332
GB - Regno Unito 329
SE - Svezia 297
MX - Messico 295
BR - Brasile 218
IN - India 217
UA - Ucraina 204
CO - Colombia 193
KR - Corea 188
FI - Finlandia 186
CA - Canada 148
VN - Vietnam 147
TR - Turchia 133
PL - Polonia 128
ID - Indonesia 119
AR - Argentina 95
RU - Federazione Russa 91
AT - Austria 89
GR - Grecia 87
AU - Australia 82
CH - Svizzera 82
NL - Olanda 81
CL - Cile 74
PT - Portogallo 72
TW - Taiwan 59
PE - Perù 55
RO - Romania 55
SA - Arabia Saudita 54
HK - Hong Kong 49
EC - Ecuador 47
TH - Thailandia 47
BE - Belgio 46
IL - Israele 45
IR - Iran 36
VE - Venezuela 32
EG - Egitto 29
SI - Slovenia 27
CZ - Repubblica Ceca 24
PK - Pakistan 22
EU - Europa 21
RS - Serbia 21
PH - Filippine 18
ZA - Sudafrica 18
NO - Norvegia 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 14
HU - Ungheria 14
TN - Tunisia 14
NG - Nigeria 12
DK - Danimarca 11
LT - Lituania 11
NZ - Nuova Zelanda 11
BG - Bulgaria 10
HR - Croazia 10
MA - Marocco 9
MY - Malesia 9
UY - Uruguay 9
UZ - Uzbekistan 9
BO - Bolivia 8
CR - Costa Rica 8
PS - Palestinian Territory 8
GT - Guatemala 7
NI - Nicaragua 7
IQ - Iraq 6
BY - Bielorussia 5
JO - Giordania 5
LB - Libano 5
LK - Sri Lanka 5
PA - Panama 5
QA - Qatar 5
GH - Ghana 4
MK - Macedonia 4
RE - Reunion 4
SK - Slovacchia (Repubblica Slovacca) 4
CM - Camerun 3
CU - Cuba 3
EE - Estonia 3
KE - Kenya 3
LI - Liechtenstein 3
NP - Nepal 3
SV - El Salvador 3
UG - Uganda 3
AN - Antille olandesi 2
IS - Islanda 2
MM - Myanmar 2
MT - Malta 2
NE - Niger 2
PY - Paraguay 2
TG - Togo 2
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BF - Burkina Faso 1
Totale 17.463
Salva come PNG Salva come JPEG
Città #
Ann Arbor 902
Chandler 543
Beijing 517
Fairfield 501
Dublin 385
Redwood City 380
Houston 362
Torino 361
Wilmington 333
Ashburn 261
Singapore 253
Woodbridge 239
Seattle 210
Villeurbanne 173
Cambridge 161
Jacksonville 148
Medford 136
Princeton 132
Pisa 121
Turin 109
Dearborn 108
Columbus 106
Nyköping 101
Milan 99
Tokyo 98
Warsaw 96
Guangzhou 95
Shanghai 88
Lubbock 83
Dong Ket 77
Fremont 66
Nanjing 65
Bogotá 63
Jakarta 63
Vienna 62
Madrid 57
Hangzhou 53
Santiago 53
Boston 49
Rome 48
San Diego 47
Medellín 45
São Paulo 43
New York 42
Barcelona 41
London 41
Buenos Aires 39
Paris 37
Lima 36
Mexico City 35
Seoul 33
Toronto 32
Guadalajara 30
Los Angeles 30
Santa Clara 30
Taipei 30
Helsinki 27
Chengdu 26
Osaka 26
Silver Spring 26
Istanbul 24
Mexico 24
Mumbai 24
Zapopan 24
Athens 23
Changsha 23
Sesto San Giovanni 23
Zhengzhou 23
Norwalk 22
Padova 22
Brussels 21
Chicago 21
Munich 21
Ottawa 21
Wuhan 21
Ankara 20
Hong Kong 20
Jinan 20
Lisbon 20
Buffalo 19
Quito 19
Cuauhtémoc 18
Gurgaon 18
Lissone 18
Phoenix 18
Berlin 17
Hanoi 17
Kunming 17
Munro 17
Riyadh 17
Boardman 16
Caracas 16
Montreal 16
Rochester 16
Zurich 16
Bucharest 15
Bangkok 14
Hefei 14
New Delhi 14
Barranquilla 13
Totale 9.215
Salva come PNG Salva come JPEG
Nome #
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.016
Acute kidney injury associated with glomerular diseases 1.012
Antiphospholipid Syndrome and the Kidney 866
Value of colchicine as treatment for recurrent oral ulcers: a systematic review 554
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 547
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 519
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 517
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 512
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 464
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 464
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 454
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 399
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 395
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 346
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 333
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 298
Upcoming biological therapies in systemic lupus erythematosus. 284
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 265
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 263
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 256
Long-term evaluation of pemphigus vulgaris: a retrospective consideration of 98 patients treated in an oral medicine unit in North-West Italy 239
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 229
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 212
Rituximab in cryoglobulinemic peripheral neuropathy 201
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 193
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 182
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 178
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 172
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 171
The prompt use of rituximab could decrease adverse effects in patient with pemphigus vulgaris: a preliminary evaluation 170
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab 167
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 162
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 160
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay 157
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 154
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 149
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 142
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris 132
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis 128
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond 127
Filling the gap in antiphospholipid syndrome diagnosis: a patient's story 122
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience 120
Short and long-term effects of Rituximab in the treatment of severe cryoglobulinaemia with and without glomerulonephritis 117
Extemporaneous orphan drugs and preparations for rare diseases: organisation and management of an inter-regional network 116
External Quality Assurance (EQA) of Immunofixation and serum free light chain measure in 9 laboratories participating in the Piedmont and Aosta Valley consortium for systemic amyloidosis 113
First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy 109
Analisi di Copy-Number Variants (CNV) e dei polimorfismi del gene C4 nelle vasculiti primitive e secondarie e nell’ artrite reumatoide. 106
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 104
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 103
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 98
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 93
C1 esterase inhibitor deficiency and SLE: A case report and review of the literature 92
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso Sistemico 88
Effetti a lungo termine del rituximab nel trattamento delle forme più severe di crioglobulinemia mista HCV associata 88
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 87
Immunological rare diseases 86
Syringomyelia and Chiari Syndrome Registry: advances in epidemiology, clinical phenotypes and natural history based on a North Western Italy cohort 85
Anticorpo monoclonale anti CD20 nella crioglobulinemia mista 83
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 81
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature 81
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort 81
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 80
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 79
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy 79
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 74
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 72
Association between hereditary angioedema and lupus erythematosus in the mother and the son 71
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia 70
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 69
Induction of remission by B lymphocyte depletion in patients with idiopathic systemic vasculitis 69
Short and long term effects on Rituximab in the treatment of severe cryoglubulinaemia with and without glomerulonephritis 67
EFFECTS OF RITUXIMAB IN THE TREATMENT OF SEVERE CRYOGLOBULINAEMIA 67
Immunogenetics of complement in mixed cryoglobulinaemia 66
INTENSIFIED B LYMPHOCYTE DEPLETION (IBLD) WITHOUT IMMUNOSUPPRESSIVE MAINTENANCE TREATMENT AS A RESCUE THERAPY IN REFRACTORY LUPUS NEPHRITIS (LN): A 4-YEAR OBSERVATION 66
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 65
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis 63
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso sistemico 62
Cryoglobulinemic glomerulonephritis: Clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy 61
Induction of remission by B lynfocyte depletion in patients with idiopathic systemic vasculitis 58
Percorso gestionale standardizzato dalla prescrizione all'erogazione di galenici magistrali per pazienti affetti da malattie rare ed allestiti presso le farmacie ospedaliere di Piemonte e Valle d'Aosta 58
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease 58
Intensified Treatment of B Lymphocyte Depletion (ITBLD) without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus Nephritis (LN): A 4-Year Observation 57
Alterazioni videocapillaroscopiche nella crioglobulinemia mista ocn danno renale 55
Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases. 55
Improving diagnosis for rare diseases: The experience of the Italian undiagnosed Rare diseases network 55
Relationship between cryoglobulinemia-associated nephritis and HCV infection 53
Malattie Rare: la rete di segnalazione 53
Rare diseases in Europe: From a wide to a local perspective 50
Purificazione e caratterizzazione di proteasomi renali umani 48
Minocycline in combination with mycophenolate mofetil in oral mucous membrane pemphigoid 48
Nail fold capillaroscopy in mixed cryoglobulinaemia 48
Orofacial granulomatosis’ features in a patient with a common variable immunodeficiency. 48
Piedmont and Aosta Valley Consortium of Systemic Amyloidosis: results of a four year experience 48
Structural and functional properties of proteasomes purified from the human kidney 47
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 47
La crioglobulinemia mista 46
VERY LONG-TERM Effects Of The "4 PLUS2 Infusion PROTOCOL" Of Rituximabalone In Patients With HCV-Associatedmixed Cryoglobulinemia With Diffusemembranoproliferative Glomerulonephritis, Severe Polyneuropathy and Necrotic Ulcersof Skin 46
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies 45
Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia 44
Long-term effects of Rituximab in the treatment of severe cryoglobluinaemia 43
Totale 17.532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.629
article - articoli 0
book - libri 0
conference - conferenze 6.401
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.030
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.698 0 0 0 0 186 280 277 214 233 186 163 159
2020/20212.400 176 153 218 116 245 197 162 173 214 239 220 287
2021/20223.033 153 163 201 295 321 286 326 273 221 178 277 339
2022/20232.496 252 194 89 175 177 524 205 221 257 113 165 124
2023/20241.791 230 224 141 134 178 132 127 114 41 134 132 204
2024/2025870 88 206 211 309 56 0 0 0 0 0 0 0
Totale 18.094